DEFA14A: Inozyme Pharma Sets Date for 2025 Annual Stockholders Meeting

Inozyme Pharma will hold its annual stockholders meeting virtually on June 25, 2025, to elect directors and ratify the appointment of Ernst & Young LLP as its independent accounting firm.

Summary

• Inozyme Pharma, Inc. will hold its Annual Meeting of Stockholders on June 25, 2025, at 9:15 AM Eastern Time.
• The meeting will be held live via the internet, and stockholders can register to attend online at www.proxydocs.com/INZY by June 23, 2025, at 5:00 PM Eastern Time.
• The agenda includes the election of three Class II directors (Sarah Bhagat, Reinaldo Diaz, and Erik Harris) for a three-year term expiring at the 2028 annual meeting.
• Stockholders will also vote on the ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
• The Board of Directors recommends voting FOR each of the director nominees and FOR the ratification of Ernst & Young LLP.
• Proxy materials, including the proxy statement and annual report, are available online at www.proxydocs.com/INZY.
• Stockholders can request paper or e-mail copies of the proxy materials by June 13, 2025, via internet, telephone, or e-mail.

Sentiment

Score: 5

Explanation: The document is a standard proxy statement, so the sentiment is neutral.

Positives

• The company is providing easy access to proxy materials online.
• Stockholders have the option to receive paper or e-mail copies of the proxy materials.
• The virtual meeting format allows for broader participation.

Future Outlook

The document outlines the standard procedures for an upcoming annual meeting, with no specific forward-looking statements about the company's financial performance or strategic direction.

Industry Context

This announcement is a routine part of corporate governance, ensuring shareholders have the opportunity to vote on key decisions and hold the company accountable.

Stakeholder Impact

• Shareholders can participate in corporate governance by voting on director elections and the appointment of the independent auditor.

Next Steps

• Stockholders should review the proxy materials.
• Stockholders should vote on the proposals.
• Interested stockholders should register to attend the virtual annual meeting by June 23, 2025.

Key Dates

Keywords

Annual Meeting, Stockholders, Proxy Statement, Directors, Ernst & Young, Voting, Inozyme Pharma